Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

NCT03734692 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer Recurrent

Interventions

DRUG: Rintatolimod
DRUG: Pembrolizumab
DRUG: Cisplatin

Sponsor

Robert Edwards

Collaborators

[object Object]
[object Object]